EDUCATION

1982 – 1986 Bachelor of Science (Zoology)

Brigham Young University

Provo, Utah

Deans Scholar: 1983, 1984, 1985, and 1986

1986 - 1990 Doctor of Medicine

University of Washington School of Medicine

Seattle, Washington

1994 - 1997 Master of Science (Public Health)

University of Utah

Salt Lake City, Utah

POSTGRADUATE MEDICAL TRAINING

1990 - 1994 Internship and Residency

University of Washington Affiliated Hospitals (Obstetrics and Gynecology)

Seattle, Washington

1994 - 1997 Fellowship

University of Utah Health Sciences (Maternal-Fetal Medicine)

Salt Lake City, Utah

BOARD CERTIFICATION

1991 Diplomate, National Board of Medical Examiners

1998 Diplomate, American Board of Obstetrics & Gynecology

Recertified Annually and Current

2000 Diplomate, Subspecialty Division of Maternal-Fetal Medicine

American Board of Obstetrics and Gynecology

Recertified Annually and Current

LICENSURE

1999 Controlled Substance (UT) – Physician (MD)

Current

1999 State License (UT) – Physician (MD)

Current

1990 DEA Certificate (UT) – Physician (MD)

Current

PROFESSIONAL TRAINING AND CERTIFICATION:

2008 National Translucency Quality Review Program

National Translucency Oversight Committee

2014 National Certification Corporation

Certification in Electronic Fetal Monitoring

ACADEMIC HISTORY

2013-present Professor (Clinical Track)

Department of Obstetrics and Gynecology

University of Utah School of Medicine, Salt Lake City, Utah

2008 – 2013 Associate Professor (Clinical Track)

Department of Obstetrics and Gynecology

University of Utah School of Medicine, Salt Lake City, Utah

2000 – 2008 Assistant Professor (Clinical Track)

Department of Obstetrics and Gynecology

University of Utah School of Medicine, Salt Lake City, Utah

1997 - 2000 Hire (instructor)

Department of Obstetrics and Gynecology

University of Utah School of Medicine, Salt Lake City, Utah

PROFESSIONAL EXPERIENCE

*main practice location

1997 – present LDS Hospital, Salt Lake City, Utah

1997 – present University of Utah Hospital, Salt Lake City, Utah

1997 – present McKay-Dee Hospital, Ogden, Utah

2007 – present Dixie Regional Medical Center, St. George, Utah

2007 – present Intermountain Medical Center, Salt Lake City, Utah*

2016 – present Utah Valley Hospital

2018 – present Layton Hospital

EDITORIAL EXPERIENCE

1997 – present American Journal of Obstetrics and Gynecology

1995 – present Obstetrics and Gynecology

SCHOLASTIC HONORS

1995 Research Award of Excellence, 15th Annual Meeting of the Society of Perinatal Obstetricians

2000 National Faculty Award for Excellence in Resident Education, Council on Resident Education in Obstetrics and Gynecology

2001 Distinguished Faculty Award, Department of Family and Preventive Medicine, University of Utah Health Sciences

2001 APGO Excellence in Teaching Award, Association of Professors of Gynecology and Obstetrics and the Department of Obstetrics and Gynecology at the University of Utah

ADMINISTRATIVE EXPERIENCE

Administrative Duties

1999 – 2007 Medical Director, Inpatient Obstetrics, LDS Hospital, Salt Lake City, Utah

2000 – 2012 Associate Program Director, Maternal-Fetal Medicine Fellowship, University of Utah Health Sciences, Salt Lake City, Utah

2001-present Medical Director, Maternal-Fetal Medicine, Intermountain Medical Center and LDS Hospital, SaltLake City, Utah

2004 – 2010 Chair, Maternal-Fetal Medicine Clinical Programs, Intermountain Healthcare, Salt Lake City, Utah

2004 – 2011 Medical Director, Intermountain Nurse Midwifery, LDS Hospital and Intermountain Medical Center, Salt Lake City, Utah

2010 – 2014 Women and Newborn Representative, Imaging Services Committee, Intermountain Healthcare, Salt Lake City, Utah

2011 – 2017 Chair, Fellowship Committee, Department of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah

2011-2020 MFM Representative, Physicians Advisory Committee, Intermountain Medical Group, Intermountain Healthcare, Salt Lake City, Utah

2012-2020 Program Director, Maternal-Fetal Medicine Fellowship, University of Utah Health School of Medicine, Salt Lake City, Utah

2017-present Co-Director, Utah Fetal Center, Primary Children’s Hospital, Salt Lake City, Utah

2016-present Medical Director, OB Transport Services, Intermountain Healthcare, Salt Lake City, Utah

2018-present Division Director, Obstetrics and Gynecology, Primary Children’s Hospital, Salt Lake City, Utah

2019-2021 Interim Medical Director, Maternal-Fetal Medicine, Intermountain Healthcare, Salt Lake City, Utah

2021-present Medical Director, Maternal-Fetal Medicine, Intermountain Healthcare, Salt Lake City, Utah

Professional and Scientific Committees

2002 – 2003 PROLOG Development Committee, American College of Obstetricians and Gynecologists, Washington, DC

2001 – 2004 Practice Bulletin Development Committee, American College of Obstetricians and Gynecologists, Washington, DC

2006 – 2009 Clinical Document Review Panel, American College of Obstetricians and Gynecologists, Washington, DC

2007 Peer Reviewer and Technical Expert: Evidence Report on “Gestational Diabetes Labor Management and Postpartum Follow-up,” American Medical Association, Washington, DC

2008 Vice-Chair, Clinical Document Review Panel – Obstetrics, American College of Obstetricians and Gynecologists, Washington, DC

2012 – 2015 Editorial Board for Clinical Updates in Women’s Healthcare, American College of Obstetricians and Gynecologists, Washington, DC

2009 Physician Consortium for Performance Improvement (PCPI)/National Committee for Quality Assurance (NCQA) Maternity Care Performance Measures Work Group, American College of Obstetrics and Gynecologists, Washington, DC

2013 – 2015 Education Committee, Society of Maternal-Fetal Medicine, Dallas, Texas

2013-present Board Examiner, Maternal-Fetal Medicine, American Board of Obstetrics of Obstetrics and Gynecologists, Dallas, Texas

2015 – 2018 Committee on Obstetrics Practice, American College Obstetricians and Gynecologists, Washington, DC

2016-2020 Publications Committee, Society of Maternal-Fetal Medicine, Dallas, Texas

2018 – 2019 Clinical Document Review Panel – Obstetrics, American College Obstetricians and Gynecologists, Washington, DC

2019 – 2021 Vice-Chair, Clinical Document Review Panel – Obstetrics, American College Obstetricians and Gynecologists, Washington, DC

2021 - Present Clinical Document Review Panel, Society of Maternal-Fetal Medicine, Dallas, Texas

2021- Present Chair, Clinical Document Review Panel – Obstetrics, American College Obstetricians and Gynecologists, Washington, DC

Symposium/Meeting Chair/Coordinator

2019 Co-Director, SMFM Postgraduate Course Director, “Beyond the Usual Suspects,” Las Vegas, Nevada

PROFESSIONAL COMMUNITY SERVICE ACTIVITIES

2006 Neonatal Resuscitation Program Training, LDS Humanitarian Services, Bangkok, Chang Mai, Chang Rai, Thailand

2012 Youth Making a Difference (YMAD), Jibhi, India

2016 Helping Babies Breath and Helping Mothers Survive, LDS Humanitarian Services, Dominican Republic

2018 Helping Babies Breath and Helping Mothers Survive, LDS Humanitarian Services, Peru

2019 Helping Babies Breath and Helping Mothers Survive, LDS Humanitarian Services, Dominican Republic

ACTIVE MEMBERSHIPS IN PROFESSIONAL SOCIETIES

1997-present Society of Maternal-Fetal Medicine

1990-present American College of Obstetricians and Gynecologists

2001-present American Institute of Ultrasound in Medicine

SELECTED POSTGRADUATE COURSES (LAST 5 YEARS)

2020 Prevention of Surgical Site Infection: Update on Perioperative Care, 35th Annual Steamboat Perinatal Conference, Steamboat Springs, Colorado

2019 Biologic Agents in Pregnancy, 39th Annual Pregnancy Meeting, Society of Maternal-Fetal Medicine, Las Vegas, Nevada

2017 Antenatal Corticosteroids for Late Preterm Birth, 32nd Annual Steamboat Perinatal Conference, Steamboat Springs, Colorado

2016 Delayed Cord Clamping , 58th Annual University of Utah Obstetrics and Gynecology Update,

Park City, Utah

2015 Obesity in Pregnancy, 30th Annual Steamboat Perinatal Conference, Steamboat Springs, Colorado

2015 Annual Antenatal Surveillance Education Conference, AWHONN and Intermountain Healthcare

Salt Lake City, Utah

PEER-REVIEWED PUBLICATIONS

1. Reisner DP, Mahony BS, Petty CN, Nyberg DA, Porter TF, Zingheim RW, Williams MA, and Luthy DA. Stuck twin syndrome: outcome in thirty-seven consecutive cases. Am J of Obstet Gynecol 1993; 169:991-5.

2. Clark SL, Hankins GDV, Dudley DA, Dildy GA, Porter TF. Amniotic fluid embolism: analysis of a national registry. Am J Obstet Gynecol 1995;172:159-69.

3. Silver RM, Porter TF, Van Leewen I, Jeng G, Branch DW, Scott JR. Anticardiolipin antibodies: clinical consequences of “low titers”. Obstet Gynecol 1996; 87:494-500.

Porter TF, Dildy GA, Blanchard JR, Kochenour NK, Clark SL. Amniotic fluid index in twin pregnancy. Obstet Gynecol, 1996; 87:699-702.
Dildy GA, Clark SL, Garite TJ, Porter TF, Swedlow DB, Varner MW. Current status of the multicenter randomized clinical trial on fetal oxygen saturation monitoring in the United States. Eur J Obstet Gynecol Reprod Bio 1997; 72: Suppl: S43-50.

6. Porter TF, Fraser AM, Hunter CY, Ward RH, Varner MW. The risk of preterm birth across generations. Obstetrics and Gynecology 1997; 90: 63-67.

7. Clark SL, Xu W, Porter TF, Love D. Institutional influences on the primary cesarean section rate in Utah, 1992-1995. Am J Obstet Gynecol 1998;179:841-5.

8. Silver RM, Porter TF, Branch DW, Esplin MS, Scott JR. Neonatal alloimmune thrombocytopenia: antenatal management. Am J Obstet Gynecol 2000; 182:1233-8.

9. Porter TF, Scott JR. Alloimmune causes of recurrent pregnancy loss. Semin Reprod Med. 2000;18(4):393-400.

10. Clark SL, Porter TF, Is vaginal birth after cesarean less expensive than repeat cesarean delivery? Am J Obstet Gynecol 2000; 182: 599-602.

11. Branch DW, Porter TF, Rittenhouse L, Caritis S, Sibai B, Hogg B, Lindheimer MD, Klebanoff M, MacPherson C, VanDorsten JP, Landon M, Paul R, Miodovnik M, Meis P, Thurnau G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Antiphospholipid antibodies in women at risk for preeclampsia. Am J Obstet Gynecol 2001 Apr;184(5):825-32.

12. Porter TF. Antiphospholipid antibodies and infertility. Clin Obstet Gynecol. 2001 Mar;44(1):29-35

13. Porter TF, Zelop C. Vaginal birth after previous cesarean delivery. ACOG Practice Bulletin No. 54. American College of Obstetricians and Gynecologists. Obstet Gynecol 2004;104:203–12.

14. Dugoff L, Hobbins JC, Malone FD, Porter TF, Luthy D, Comstock CH, Hankins G, Berkowitz RL, Merkatz I, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Vidaver J, D’ Alton ME. First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial). Am J Obstet Gynecol. 2004 Oct;191(4):1446-51.

15. Sullivan AE, Silver RM, LaCoursiere DY, Porter TF, Branch DW. Recurrent fetal aneuploidy and recurrent miscarriage. Obstet Gynecol. 2004 Oct;104(4):784-8.

16. Frias AE Jr, Luikenaar RA, Sullivan AE, Lee RM, Porter TF, Branch DW, Silver RM. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol. 2004 Sep;104(3):521-6.

17. Porter TF, Zelop C. Vaginal birth after previous cesarean delivery. ACOG Practice Bulletine No. 54, Obstet Gynecol, 2004 104, 203-12.

18. Frias AE Jr, Luikenaar RA, Sullivan AE, Lee RM, Porter TF, Branch DW, Silver RM. Poor obstetric outcome in subsequent pregnancies in women with prior fetal death. Obstet Gynecol, 2004 104(3),521-6.

19. Porter TF, Scott JR. Evidence-based care of recurrent miscarriage. Best Pract Res 2005 Clin Obstet Gynecol, 19(1), 85-101.

20. Sullivan AE, Nelson L, Rice JA, Porter TF, Branch DW, Silver RM. The factor V Leiden and the G20210A prothrombin gene mutations are rare in women with fetal death. Am J Reprod Immunol, 2005 54(1), 1-4.

21. Dugoff L, Hobbins JC, Malone FD, Vidaver J, Sullivan L, Canick JA, Lambert-Messerlian GM, Porter TF, Luthy DA, Comstock CH, Saade G, Eddleman K, Merkatz IR, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’Alton ME. Quad screen as a predictor of adverse pregnancy outcome. Obstet Gynecol, 2005 106(2), 260-7.

22. Shevell T, Malone FD, Vidaver J, Porter TF, Luthy DA, Comstock CH, Hankins GD, Eddleman K, Dolan S, Dugoff L, Craigo S, Timor IE, Carr SR, Wolfe HM, Bianchi DW, D;Alton ME. Assisted reproductive technology and pregnancy outcome. Obstet Gynecol 2005 Nov ;106(5):1039-1045

23. Sullivan AE, Nelson L, Frias AE, Porter TF, Branch DW, Silver RM. The aryl hydrocarbon receptor nuclear translocator gene polymorphism in patients with recurrent miscarriage. Am J Reprod Immunol. 2006 Jan;55(1):51-3.

24. Holmgren C, Porter TF. Management of RhD allomunization in pregnancy. ACOG Practice Bulletin, 2006.

25. Yeast J, Peaceman A, Carlan S, Morrison J, Porter TF, Perlow J, Colombo D, Goodwin T, Hickock D, Williams C, Boch D, Garite T. A positive fetal fibronectin test is associated with more favorable induction of labor outcomes. Am J Obstet Gynecol 2006, in press.

26. Healy AJ, Malone FD, Sullivan LM, Porter TF, Luthy DA, Comstock CH, Saade G, Berkowitz R, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch I, Carr SR, Wolfe HM, Bianchi DW, D’Alton MD. Early access to prenatal care: implications for racial disparity in perinatal mortality. Obstet Gynecol. 2006 Mar;107(3):625-631.

27. Eddleman KA, Malone FD, Sullivan L, Dukes K, Berkowitz RL, Kharbutli Y, Porter TF, Luthy DA, Comstock CH, Saade GR, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’ Alton ME. Pregnancy loss rates after midtrimester amniocentesis. Obstet Gynecol. 2006 Nov;108(5):1067-72.

28. Crombleholme, TM, Shera, D, Lee, H, Johnson, M, D’ Alton, M, Porter, TF, Chyu, J, Silver, R, Abuhamad, A, Saade, G, Shields, L, Kauffman,D, Stone, J, Albanese, CT, Bahado-Singh, R, Ball, RH, Bilaniuk, L, Coleman, B, Farmer, D, Feldstein, V, Harrison, MR, Hedrick, H, Livingston, J, Lorenz, RP, Miller, DA, Norton, ME, Polzin, WJ, Robinson, JN, Rychik, J, Sandberg, PL, Seri, I, Simon, E, Simpson, LL, Yedigarova, L, Wilson, RD, Young, B. A prospective randomized multicenter trial of amnioreduction versus selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2007; 197(4):396

29. Dolan S, Gross SJ, Merkatz IR, Faber V, Sullivan LM, Malone FD, Porter TF, Nyberg DA, Comstock CH, Hankins GD, Eddleman K, Dugoff L, Craigo SD, Timor-Tritsch I, Carr SR, Wolfe HM, Bianchi DW, D’ Alton ME. The contribution of birth defects to prematurity and low birth weight. Obstet Gynecol. 2007 Aug;110(2 Pt 1):318-24.

30. Warren JE, Silver RM, Dalton J, Nelson LT, Branch DW, Porter TF. Collagen 1Alpha1 and transforming growth factor-beta polymorphisms in women with cervical insufficiency. Obstet Gynecol. 2007 Sep;110(3):619-24.

31. Breathnach FM, Malone FD, Lambert-Messerlian G, Cuckle HS, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Klugman S, Dugoff L, Craigo SD, Timor-Tritsch E, Carr SR, Wolfe HM, Tripp T, Bianchi DW, D’ Alton ME. First and second-trimester screening: detection of aneuploidies other than Down syndrome. Obstet Gynecol. 2007 Sep;110(3):651-7.

32. Holmgren C, Aagaard-Tillery KM, Silver RM, Porter TF, Varner M. Hyperemesis in pregnancy: an evaluation of treatment strategies with maternal and neonatal outcomes. Am J Obstet Gynecol. 2008 Jan;198(1):56.e1-4.

33. Aagaard-Tillery KM, Porter TF, Lane RH, Varner MW, Lacoursiere DY. In utero tobacco exposure is associated with modified effects of maternal factors on fetal growth. Am J Obstet Gynecol. 2008 Jan;198(1):66.e1-6.

34. Cuckle HS, Malone FD, Wright D, Porter TF, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Ferreira JSC, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, D’ Alton ME. Contingent screening for Down syndrome – results from the FaSTER trial. Prenat Diagn 2008 Feb; 28(2):89-94.

35. Lambert-Messerlian, G McClain, M, Haddow, JE, Palomaki, GE, BS, Canick, JA, Cleary-Goldman, J, Malone, FD, Porter TF, MD, Nyberg, DA, Gross, SJ, D’alton, ME. First and second trimester thyroid hormone reference data in pregnant women: a FASTER (first and second trimester evaluation of risk for aneuploidy) research consortium study. Am J Obstet Gynecol. 2008 Jul;199:62.el-6

36. Cleary-Goldman J, Malone FD, Lambert-Messerlian G, Sullivan L, Canick J, Porter TF, Luthy D, Gross S, Bianchi DW, D’ Alton ME. Maternal thyroid hypofunction and pregnancy outcome. Obsteg Gynecol. 2008 Jul;112:85-92.

37. McClain MR, Lambert-Messerlian G, Haddow JE, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernstein P, D’ Alton ME; FaSTER Research Consortium. Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study. Am J Obstet Gynecol. 2008 Aug;199(2):129.e1-6.

38. Haddow JE, McClain M, Lambert-Messerlian G, Palomaki GE, Canick JA, Cleary-Goldman J, Malone FD, Porter TF, Nyberg DA, Bernsetin P, D’ Alton ME. Variability in thyroid-stimulating hormone suppression by human choronic gonadotropin during early pregnancy. J Clin Endocrinol Metab. 2008 Sep;93(9):3341-7

39. Hoffman JD, Bianchi DW, Sullivan LM, Mackinnon BL, Collins J, Malone FD, Porter TF, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’ Alton MD. Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele. Prenat Diagn. 2008 Dec;28(13):1204-8.

40. Warren JE, Simonsen SE, Branch DW, Porter TF, Silver RM. Thromboprophylaxis and pregnancy outcomes in asymptomatic women with inherited thrombophilias. Am J Obstet Gynecol. 2009 Mar; 200(3):281.e1-5. Epub 2008 Dec 27.

41. Bukowski R, Malone FD, Porter TF, Nyberg DA, Comstock CH, Hankins GDV, Eddleman K, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, D’ Alton ME. Preconceptional folate supplementation and the risk of spontaneous preterm birth. Lancet, PLoS Med. 2009 May 5; 6(5):e1000061.

42. Eller AG, Porter TF, Soisson P, Silver R. Optimal management strategies for placenta accreta. BJOG. 2009 Apr; 116(5):648-54. Epub 2009 Feb 4.

43. Aagaard-Tillery AM, Malone FD, Nybert DA, Porter TF, Cuckle H, Fuchs K, Sullivan L, Comstock CH, Saade GR, Eddleman K, Gross S, Dugoff L, Craigo SD, Timor IE, Carr SR, Wolfe HM, Bianchi DW, D’ Alton ME, for the FaSTER Research Consortium. Role of second trimester genetic sonography following Down Syndrome screening. Obstet & Gynecol 2009 Dec; 114(6):1189-96.

44. Haddow JE, Cleary-Goldman J, McClain M, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein P, D’Alton ME, for the FaSTER Research Consortium. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery. Obstet & Genycol. 2010 Jul;116(1):58-62.

45. Branch DW, Silver RM, Porter TF. Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus 2010; 19(4):446-52.

46. Heuser C, Dalton J, Macpherson C, Branch DW, Porter TF, Silver RM. Idiopathic recurrent pregnancy loss recurs at similar gestational ages. Am J Obstet Gynecol 2010 Oct;203(4):343-345.

47. Eller AG, Branch DW, Nelson L, Porter TF, Silver RM. Vascular endothelial growth factor-A gene polymorphisms in women with recurrent pregnancy loss. J Reprod Immunol 2011 Jan;88(1):48-52.

49. Haddow JE, McClain MR, Palomaki GE, Neveux LM, Lambert-Messerlian G, Canick JA, Malone FD, Porter TF, Nyberg DA, Bernstein PS, D’Alton ME; First and Second Trimester Risk of Aneuploidy (FaSTER) Research Consortium. Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption. Obstet Gynecol 2011 Feb;117(2Pt1):287-92.

50. Manuck TA, Henry E, Gibson J, Varner M, Porter TF, Jackson GM, Esplin, MS. Pregnancy outcomes in a recurrent preterm birth prevention clinic. Am J Obstet Gynecol 2011 Apr;204(4):320,e1-6.

51. Horne BD, Rasmusson KD, Alharethi R, Budge D, Brunisholz KD, Metz T, Carlquist JF, Connolly JJ, Porter, TF, Lappe’ DL, Muhlestein JB, Silver R, Stehlik J, Park JJ, May HT, Bair TL, Anderson JL, Renlund DG, Kfoury AG. Genome-wide significance and replication of the chromosome 12p11.22 locus near the PTHLH gene for peripartum cardiomyopathy. Circulation Cardiovascular Genetics 2011 Aug;4:359-66.

52. Holmgren C, Scott JR, Porter TF, Esplin MS, Bardsley T. Uterine rupture with attempted vaginal birth after cesarean delivery: decision-to-delivery time and neonatal outcome. Obstet Gynecol 2012 Apr:119(4):725-31.

53. Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, Petri M, Porter TF, Sammaritano L, Stephenson MD, Buyon J, Salmon JE. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012 Jul;64:2311-2318.

54. Holmgren C, Scott JR, Porter TF, Esplin MS, Bardsley T. (2012). Uterine rupture with attempted vaginal birth after cesarean delivery: decision-to-delivery time and neonatal outcome. Obstet Gynecol Apr;119(4):725-31.

55. Wong LF, Porter TF, De Jesus G. Recurrent early pregnancy loss and antiphospholipid antibodies: where do we stand? Lupus. 2014 Oct;23(12):1226-8.

56. Romero ST, Holmgren CC, Feltovich H, Porter TF, Esplin MS. (2014) Cervical length screening: a randomized trial assessing impact on visit length and patient attitudes. J Ultrasound Med 2014; 33:2159-63.

57. Buyon J, Kim MY, Guerra MM, Laskin CA, Petri M, Lockshin MD, Sammaritano L, Branch DW, Porter TF, Sawitzkie A, Merrill JT, Stephenson MD, Cohn E, Garabet G, Salmon JE. Predictors of Pregnancy Outcome in a Prospective, Multiethnic Cohort of Lupus Patients. Ann Intern Med. 2015 Aug 4;163(3):153-63.

58. Ramires de Jesús G, Levy RA, Porter TF, Branch DW. Limited evidence for diagnosing and treating "non-criteria obstetric antiphospholipid syndrome.” Thromb Haemost. 2015 Aug 31;114(3):651-2.

59. Anand S, Alvarez TMB. Johnson WE, Esplin MS, Merrell K, Porter TF, Graves SW. Serum biomarkers predictive of preeclampsia. Biomark Med. 2015;9(6):563-75

60. Gibbins KJ, Weber T, Holmgren CM, Porter TF, Varner MW, Manuck TA. Maternal and fetal morbidity associated with uterine rupture of the unscarred uterus. Am J Obstet Gynecol. 2015 Sep;213(3):382.e1-6

61. de Jesus GR, Agmon-Levin N, Andrade CA, Andreoli L, Chighizola CB, Porter TF, Salmon J, Silver RM, Tincani A, Branch DW. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev. 2014 Aug;13(8):795-813.

62. Holmgren CM, Esplin MS, Jackson M, Porter TF, Henry E, Horne BD, Varner MW. A risk stratification model to predict adverse neonatal outcome in labor. J Perinatol. 2013 Dec;33(12):914-8.

63. Bowman ZS, Wünsche V, Porter TF, Silver RM, Branch DW. Prevalence of antiphospholipid antibodies and risk of subsequent adverse obstetric outcomes in women with prior pregnancy loss. J Reprod Immunol. 2015 Feb;107:59-63.

64. Manuck TA, Herrera CA, Korgenski EK, Jackson M, Stoddard GJ, Porter TF, Varner MW. Tocolysis for Women With Early Spontaneous Preterm Labor and Advanced Cervical Dilation. Obstet Gynecol. 2015 Nov;126(5):954-61.

65. Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR, Kim MY, Salmon JE. Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med. 2016 Jan 12;3(1):e000131.

66. Kim MY, Buyon JP, Guerra MM, Rana S, Zhang D, Laskin CA, Petri M, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Merrill JT, Stephenson MD, Gao Q, Karumanchi SA, Salmon JE. Angiogenic factor imbalance early in pregnancy predicts adverse outcomes in patients with lupus and antiphospholipid antibodies: results of the PROMISSE study. Am J Obstet Gynecol. 2016 Jan;214(1):108.e1-108.e14.

67. Yelnik CM, Porter TF, Branch DW, Laskin CA, Merrill JT, Guerra MM, Lockshin MD, Buyon JP, Petri M, Sammaritano LR, Stephenson MD, Kim MY, Salmon JE. Changes in Antiphospholipid Antibody Titers during Pregnancy: Data from the PROMISSE Study. Arthritis Rheumatol. 2016 Mar 18. doi: 10.1002/art.39668. [Epub ahead of print]

68. Folsom S, Esplin MS, Edmunds S, Metz TD, Jackson GM, Porter TF, Varner MW. Patient Counseling and Preferences for Elective Repeat Cesarean Delivery. AJP Rep. 2016 Apr;6(2):e226-31.

69. Anand S, Young S, Esplin MS, Peaden B, Tolley HD, Porter TF, Varner MW, D'Alton ME, Jackson BJ, Graves SW. Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry. J Lipid Res. 2016 Apr;57(4):687-96.

70. Buyon JP, Kim MY, Guerra MM, Lu S, Reeves E, Petri M, Laskin CA, Lockshin MD, Sammaritano LR, Branch DW, Porter TF, Sawitzke A, Merrill JT, Stephenson MD, Cohn E, Salmon JE. Kidney Outcomes and Risk Factors for Nephritis (Flare/De Novo) in a Multiethnic Cohort of Pregnant Patients with Lupus. Clin J Am Soc Nephrol. 2017 Jun 7;12(6):940-946.

71. Mascola MA, Porter TF, Chao TT. Committee on Obstetric Practice. Committee Opinion No. 684: Delayed Umbilical Cord Clamping After Birth. Obstet Gynecol. 2017 Jan;129(1):e5-e10

72. Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, Lockshin MD, Sammaritano LR, Merrill JT, Porter TF, Sawitzke A, Lynch AM, Buyon JP, Salmon JE. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Ann Rheum Dis. 2018 Apr;77(4):549-555

73. Porter TF, Gyamfi-Bannerman C, Manuck T. Committee on Obstetric Practice. Committee Opinion No. 743: Low-Dose Aspirin Use During Pregnancy. Obstet Gynecol. 2018 Jul;132(1):e44-e52.

74. Hong S, Banchereau R, Maslow BL, Guerra MM, Cardenas J, Baisch J, Branch DW, Porter TF, Sawitzke A, Laskin CA, Buyon JP, Merrill J, Sammaritano LR, Petri M, Gatewood E, Cepika AM, Ohouo M, Obermoser G, Anguiano E, Kim TW, Nulsen J, Nehar-Belaid D, Blankenship D, Turner J, Banchereau J, Salmon JE, Pascual V. Longitudinal Profiling of Human Blood Transcriptome in Healthy and Lupus Pregnancy. J Exp Med. 2019 May 6;216(5):1154-1169.

REVIEW ARTICLES

1. Porter TF, Silver RM, Jackson GM, Branch DW, Scott JR. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 1997; 52:193-7. Review

2. Dudley DJ, Porter TF, Scott JR. Potential of immune-therapeutic treatment for recurrent pregnancy loss. BioDrugs, 1997, 7, 249-53. Review

3. Porter TF, Varner MW. Using evidence-based medicine to optimize cesarean section outcomes. Clin Obstet Gynecol, 1997, 40, 542. Review

4. Madden SA, Porter TF. Deep Venous Thrombosis: Prophylaxis in Gynecology. Clin Obstet Gynecol, 1999, 42, 895-901. Review

5. Porter TF, Clark SL. Vibroacoustic Stimulation and Scalp Stimulation. Obstet Gynecol Clin North Am, 1999;26,657-69. Review

6. Porter TF, Scott JR. Alloimmune Causes of Recurrent Pregnancy Loss. Semin Reprod Med, 2000; 18,393-400. Review

7. Porter TF. Antiphospholipid Antibodies and Infertility. Clin Obstet Gynecol, 2000;44,29-35. Review

8. Clark SL, Porter TF, West FG. Coumarin derivatives and breast-feeding. Obstet Gynecol. 2000; 95: 938-40. Review

9. Branch DW, Porter TF, Paides MJ, Belfort MA, Gonik B. Obstetric uses of intravenous immunoglobulin: successes, failures, and promises. J Allergy Clin Immunol 2001; 108: S133-S138. Review

10. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD000112. Review.

11. Wong LF, Porter TF, Scott JR. Immunotherapy for Recurrent Miscarriage. Cochrane Database Syst Rev. 2014 Oct 21;10:CD000112.

12. Gibbins K, Porter TF. The Importance of an Evidence-based Workup for Recurrent Pregnancy Loss. Clin Obstet Gynecol. 2016 Sep;59(3):456-63.

13. Hammad I, Porter TF. An Update on Biologic Agents During Pregnancy. Clin Perinatol. 2020 Dec;47(4):733-742. doi: 10.1016/j.clp.2020.08.003. Epub 2020 Oct 16. PMID: 33153658

CHAPTERS IN SCIENTIFIC TEXTBOOKS

Porter TF, Clark SL. Asthma. In: Gleicher N, ed. Principles and practice of medical therapy in pregnancy. New York, Appleton and Lange, 1997.
Porter TF, Acute fatty liver of pregnancy. In: Clark SL, Cotton DB, Hankins GDV, Phelan J, eds. Critical Care Obstetrics, Third Edition. Boston, Blackwell Scientific Publications, 1997.
Porter TF, Branch DW. Autoimmune disease in pregnancy. In: James DK, Steer PJ, Reiner CP, Gonik B. High Risk Pregnancy: Management Options, Second Edition. London, W B Saunders, LTD, 1997.
Branch, DW, Porter TF. Hypertensive disorders of pregnancy. In: Scott JR, DiSaia P, Hammond C, Spellacy W, Branch DW. Danforth’s Obstetrics and Gynecology, Eighth Edition. Philadelphia, 1998.
Porter TF, Branch DW. Pregnancy and antiphospholipid antibodies. In: Khamashta MA. Hughes Syndrome, Antiphospholipid Syndrome. London, Springer, 2000.
Porter TF, Peltier M, Branch DW, Immunologic disorders in pregnancy. In Scott JR, Gibbs RS, Karlan BY, Haney AF, eds. Danforth’s Obstetrics and Gynecology, Ninth Edition. Philadelphia, Lippincott Williams & Wilkins, 2003.
Porter TF, Scott JR. Cesarean delivery. In Scott JR, Gibbs RS, Karlan BY, Haney AF, eds. Danforth’s Obstetrics and Gynecology, Ninth Edition. Philadelphia, Lippincott Williams & Wilkins, 2003.
Porter TF, Acute fatty liver of pregnancy. In: Dildy G, Belfort M, Saade G, Phelan J, Hankins G, Clark SL, eds. Critical Care Obstetrics, Fourth Edition. Boston, Blackwell Scientific Publications, 2004.
Porter TF, Branch DW. Systemic lupus erythematosus and the antiphospholipid syndrome. In: Dildy G, Belfort M, Saade G, Phelan J, Hankins G, Clark SL, eds. Critical Care Obstetrics, Fourth Edition. Boston, Blackwell Scientific Publications, 2004.
Porter TF, Branch DW. Autoimmune disease in pregnancy. In: James DK, Steer PJ, Reiner CP, Gonik B. High Risk Pregnancy: Management Options, Third Edition. Philadelphia, Elsevier, 2005.
Porter TF, Silver RM, Branch DW. Obstetric antiphospholipid syndrome. In: Khamashta MA. Hughes Syndrome, Antiphospholipid Syndrome, Second Edition. London, Springer, 2006.
Porter TF, Silver RM, Branch DW. Obstetric antiphospholipid syndrome. In Hughes Syndrome: Antiphospholipid Syndrome (MA Khamashta). 2nd edition, London, Springer-Verlag, 2006; 181-196.
Porter TF, Scott JR. Cesarean delivery. In Scott JR, Gibbs RS, Karlan BY, Haney AF, eds. Danforth’s Obstetrics and Gynecology, 10th Edition. Philadelphia, Lippincott Williams & Wilkins, 2008.
Porter TF. Recurrent Miscarriage. In Scott JR, Gibbs RS, Karlan BY, Haney AF, eds. Danforth’s Obstetrics and Gynecology, 10th Edition. Philadelphia, Lippincott Williams & Wilkins, 2008.
Porter TF, Acute fatty liver of pregnancy. In: Dildy G, Belfort M, Saade G, Phelan J, Hankins G, Clark SL, eds. Critical Care Obstetrics, Fifth Edition. Boston, Blackwell Scientific Publications. 2010.
Porter TF, Branch DW. Systemic lupus erythematosus and the antiphospholipid syndrome. In: Dildy G, Belfort M, Saade G, Phelan J, Hankins G, Clark SL, eds. Critical Care Obstetrics, Fifth Edition. Boston, Blackwell Scientific Publications, 2010.
Denney JM, Porter TF, Branch DW. Autoimmune disease in pregnancy. In: James DK, Steer PJ, Reiner CP, Gonik B. High Risk Pregnancy: Management Options, Fourth Edition. Philadelphia, Elsevier, 2011.
Kfoury AG, Rasmusson KD, Brunisholz KD, Porter TF, Horne BD. Peripartum cardiomyopathy. In: K. Stergiopoulos, D.L. Brown (eds.), Evidence-Based Cardiology Consult, Springer-Verlag London 2014.

PRESENTATIONS AT SCIENTIFIC MEETINGS

Oral Presentations

"The Importance of IgM Anticardiolipin Antibodies in Antiphospholipid Syndrome." Annual Meeting of the Society of Gynecologic Investigation, March 23-27, 1994, Chicago, Illinois.
“Regional Preterm Birth Subsets”. Fellows’ Plenary Session, 16th Annual Meeting of the Society of Perinatal Obstetricians, Hapuna, Hawaii, February 4 - 10, 1996.
“Survival and Neurologic Outcome of Apparently Stillborn Infants.” Fellows’ Plenary Session, 17th Annual meeting of the Society of Perinatal Obstetricians, Anaheim, California, 1997.
“Timing of Delivery and Neonatal Outcome in Patients with Clinically Overt Uterine Rupture during VBAC”, 18 Annual meeting of the Society of Perinatal Obstetricians, Miami, Florida, 1998.
“The Prevalence And Clinical Consequences Of Antibodies To 2 Glycoprotein I In The General Obstetric Population,” International Congress of Antiphospholipid Syndrome, Taormina, Giardi-Naxos, Sicily, Italy, 2001.
“Determinants Of Fetal Growth Impairment.” Oral concurrent session 4, 25th Annual meeting of the Society of Maternal-Fetal Medicine, Reno, Nevada, 2005.
“APS Task Force 2 - Obstetric Diagnostics and Treatment” and “Debate Session 3- Obstetrics, SLE & APS. APLA & LACA 2013 14th International Congress on Antiphospholipid Antibodies & 4th Latin American Congress on Autoimmunity. Rio de Janeiro, Brazil. September 2013

Poster Presentations

"Stuck Twin Syndrome: Outcome in thirty-seven consecutive cases." 13th Annual Meeting of the Society of Perinatal Obstetricians, February, 9-13, 1993, San Francisco, California.
"The Value of Routine Antepartum Surveillance in Twin Gestation." 15th Annual Meeting of the Society of Perinatal Obstetricians, January 25-28, 1994, Atlanta, Georgia.
"Amniotic Fluid Index in Twin Gestations." 15th Annual Meeting of the Society of Perinatal Obstetricians, January 25-28, 1994, Atlanta, Georgia. Winner of the Excellence in Research Award for Poster Session.
“Antenatal Management of Alloimmune Thrombocytopenia.” Annual Meeting of the Society of Gynecologic Investigation, March 16-19, 1995. Chicago, Illinois.
“Acoustic Stimulation in the Antepartum Management of Twin Pregnancies”. 16th Annual Meeting of the Society of Perinatal Obstetricians, Hapuna, Hawaii, February 4 - 10, 1996.
”Unexplained Disseminated Intravascular Coagulation in Pregnancy”. 16th Annual Meeting of the Society of Perinatal Obstetricians, Hapuna, Hawaii, February 4 - 10, 1996.
“Familial Aggregation of Preterm Birth”. Annual Meeting of the Society of Gynecologic Investigation, Philadelphia, Pennsylvania, March 18 - 23, 1996.
“Antiphospholipid antibodies are not associated with failure of in vitro fertilization and embryo transfer. Annual Meeting of the Society of Gynecologic Investigation, Atlanta, Georgia, March 11-15, 1998.
“Idiopathic polyhydramnios is associated with increased prenatal and neonatal complications, 17th Annual Meeting of the Society of Perinatal Obstetricians, Miami, Florida, 1998.
“Optimal management of placenta accreta.” 27th Annual meeting of the Society of Maternal-Fetal Medicine, San Francisco, California, 2007.